↑ トップへ　← 戻る

 Drug（薬物リスト） DrugBank | All Description Patterns💬 Info on mouse-over

e.g. Sirolimus, アダリムマブ

ABCDEFGH I JKLMNOPQRSTUVWXYZother

191 / 17,542 descriptions

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY
On map, Yellow: Drug target genes		 指定難病告示番号
1 (cdp6038 - - - - 1件: 46 💬
2 2-cda Cladribine 1件: D01370 💬 1件: RRM1 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 1件: 13 💬
3 2-cda, 2-chloro-2'-deoxy-beta-d-adenosine Adenosine 2件: D00045, D01370 💬 5件: ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬 17件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 13 💬
4 2-cda, 2-chloro-2'-deoxy-ß-d-adenosine Adenosine 2件: D00045, D01370 💬 5件: ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬 17件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 13 💬
5 2-cda, 2-chloro-2?-deoxy-beta-d-adenosine Adenosine 2件: D00045, D01370 💬 5件: ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬 17件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 13 💬
6 2-cda, 2-chloro-2?-deoxy-ß-d-adenosine Adenosine 2件: D00045, D01370 💬 5件: ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬 17件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 13 💬
7 2-cda, 2-chloro-2’-deoxy-beta-d-adenosine Adenosine 2件: D00045, D01370 💬 5件: ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬 17件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 13 💬
8 2-cda, 2-chloro-2’-deoxy-ß-d-adenosine Adenosine 2件: D00045, D01370 💬 5件: ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬 17件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 13 💬
9 2-chloro-2'-deoxy-beta-d-adenosine (2-cda) Adenosine 2件: D00045, D01370 💬 5件: ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬 17件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 13 💬
10 2-chloro-2'-deoxy-ß-d-adenosine (2-cda) Adenosine 2件: D00045, D01370 💬 5件: ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬 17件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 13 💬
11 2-chloro-2'-deoxyadenosine (2-cda) Cladribine 1件: D01370 💬 1件: RRM1 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 1件: 13 💬
12 2-chloro-2’-deoxy-beta-d-adenosine (2-cda) Adenosine 2件: D00045, D01370 💬 5件: ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬 17件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 13 💬
13 2-chloro-2’-deoxy-ß-d-adenosine (2-cda) Adenosine 2件: D00045, D01370 💬 5件: ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬 17件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 13 💬
14 2-chloro-2’-deoxyadenosine (2-cda) Cladribine 1件: D01370 💬 1件: RRM1 💬 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 1件: 13 💬
15 Adeno-associated virus serotype 2/6 encoding human alpha-galactosidase a cdna Agalsidase alfa 1件: D02784 💬 1件: GLA 💬 6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 1件: 19 💬
16 Allo-asc-cd - - - - 1件: 96 💬
17 Anti cd3 monoclonal antibody - - - - 1件: 97 💬
18 Anti-cd19-car-t cells - - - - 1件: 49 💬
19 Anti-cd20 b cell depletion with truxima - - - - 1件: 49 💬
20 Anti-cd20 small modular immunopharmaceutical, wye-400087 - - - - 1件: 46 💬
21 Anti-cd25 humanized monoclonal antibody - - - - 1件: 13 💬
22 Anti-cd28dab - - - - 3件: 49, 53, 160 💬
23 Anti-cd3 Muromonab 1件: D05092 💬 3件: CD3D, CD3E, CD3G 💬 11件: Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 2件: 96, 97 💬
24 Anti-cd3 monoclonal antibody Muromonab 1件: D05092 💬 3件: CD3D, CD3E, CD3G 💬 11件: Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 2件: 96, 97 💬
25 Anti-cd40l Toralizumab 1件: D06193 💬 1件: CD40LG 💬 13件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, Malaria, NF-kappa B signaling pathway, Primary immunodeficiency, Systemic lupus erythematosus, T cell receptor signaling pathway, Toxoplasmosis, Viral myocarditis 1件: 63 💬
26 Anti-cd40ldab - - - - 1件: 63 💬
27 Anti-cd45 - - - - 3件: 60, 65, 285 💬
28 Anti-cd52 monoclonal antibody - - - - 1件: 13 💬
29 Ap-cd/ld - - - - 1件:  6  💬
30 Autologous cd34+ cell transduced with g2scid vector - - - - 1件: 65 💬
31 Autologous cd34+ cells transduced ex-vivo with the pcclchimgp91/vsvg lentiviral vector - - - - 1件: 65 💬
32 Autologous cd34+ cells transduced with a lentiviral vector containing the human sgsh gene - - - - 1件: 19 💬
33 Autologous cd34+ cells transduced with a lentiviral vector encoding the arsa cdna - - - - 1件: 19 💬
34 Autologous cd34+ cells transduced with lenti-d vector encoding abcd1 cdna - - - - 1件: 20 💬
35 Autologous cd34+ cells transduced with the lentiviral vector containing the human wiskott aldrich sy - - - - 1件: 65 💬
36 Autologous cd34+ enriched cell fraction that contains cd34+ cells transduced with lentiviral vector that encodes for the human wiskott aldrich syndrome (was) cdna sequence - - - - 1件: 65 💬
37 Autologous cd34+ hscs transduced ex vivo with efs lentiviral vector encoding for the human ada gene - - - - 1件: 65 💬
38 Autologous cd34+cells transduced with the w1.6_hwasp_wpre (vsvg) lentiviral vector - - - - 1件: 65 💬
39 Autologous cd34-selected peripheral blood stem cells transplant - - - - 1件: 96 💬
40 Autologous cd4+t cells stimulated and expanded ex vivo by a mog peptide modified by the introduction of a thioreductase motif into the flanking residues of the t cell epitope - - - - 1件: 13 💬
41 Autologous haematopoietic stem cells transduced with lentiviral vector lenti-d encoding the human abcd1 cdna - - - - 1件: 20 💬
42 Autologous stemcell transplantation with cd (cluster of differentiation) 34 selected stem cells - - - - 1件: 51 💬
43 Bardoxolone methyl, cddo-me, cddo-methyl ester, nsc 713200, chemical name: oleana-1,9(11)-dien-28-oic acid, 2-cyano-3,12-dioxo-, methyl ester Bardoxolone 2件: D09584, D09585 💬 - - 1件: 86 💬
44 Biologic: ic14 (monoclonal antibody against human cd14) - - - - 1件:  2  💬
45 Blinded cdca 250 mg tid Chenodeoxycholic acid 1件: D00163 💬 1件: NR1H4 💬 1件: Bile secretion 1件: 263 💬
46 Bt061 (cd4 monoclonal antibody) - - - - 1件: 46 💬
47 Cd - - - - 6件:  6 , 46, 51, 96, 97, 265 💬
48 Cd-4 guided therapy interruption - - - - 1件: 265 💬
49 Cd-ld cr - - - - 1件:  6  💬
50 Cd-ld ir - - - - 1件:  6  💬
51 Cd19-directed humanised afucosylated monoclonal antibody - - - - 1件: 11 💬
52 Cd3/cd19 depleted leukocytes - - - - 1件: 284 💬
53 Cd3/cd19 neg allogeneic bmt - - - - 1件: 65 💬
54 Cd3/cd19 negative allogeneic hematopoietic stem cells - - - - 1件: 65 💬
55 Cd3/cd19 negative hematopoietic stem cells - - - - 1件: 85 💬
56 Cd34 selected autologous hematopoietic cells - - - - 1件: 51 💬
57 Cd34 stem cell selection therapy - - - - 3件: 60, 65, 284 💬
58 Cd34+ - - - - 1件: 65 💬
59 Cd34+ bone marrow stem cells intravitreal - - - - 1件: 90 💬
60 Cd34+ cells - - - - 1件: 285 💬
61 Cd34+ cells transduced with ada retrovir - - - - 1件: 65 💬
62 Cd34+ enriched, t cell depleted donor stem cell product - - - - 1件: 326 💬
63 Cd34+ hscs transduced with the lentivirus vector, vsv-g pseudotyped cl20-4i-ef1a-h?c-opt - - - - 1件: 65 💬
64 Cd34+ selected cells - - - - 1件: 285 💬
65 Cd34+cells - - - - 2件: 65, 285 💬
66 Cd34+sc - - - - 1件: 51 💬
67 Cd45ra depleted leukocytes - - - - 1件: 284 💬
68 Cd45ra-depleted dli - - - - 2件: 60, 65 💬
69 Cd62l- tem - - - - 1件: 60 💬
70 Cdca Chenodeoxycholic acid 1件: D00163 💬 1件: NR1H4 💬 1件: Bile secretion 1件: 263 💬
71 Cdca weight-based dose tid Chenodeoxycholic acid 1件: D00163 💬 1件: NR1H4 💬 1件: Bile secretion 1件: 263 💬
72 Cdmard - - - - 1件: 46 💬
73 Cdnf - - - - 1件:  6  💬
74 Cdp - - - - 1件: 46 💬
75 Cdp 6038 sc - - - - 1件: 46 💬
76 Cdp3194 - - - - 1件: 49 💬
77 Cdp323 CDP323 - - - 1件: 13 💬
78 Cdp6038 - - - - 2件: 46, 96 💬
79 Cdp7657 - - - - 1件: 49 💬
80 Cdp870 - - - - 3件: 46, 96, 271 💬
81 Cdp870 100mg - - - - 1件: 46 💬
82 Cdp870 200mg - - - - 1件: 46 💬
83 Cdp870 400mg - - - - 1件: 46 💬
84 Cdp870 fab'-peg - - - - 1件: 46 💬
85 Cdx - - - - 3件: 222, 223, 240 💬
86 Cdx 6114 - - - - 1件: 240 💬
87 Cdx-1135 - - - - 2件: 222, 223 💬
88 Cdz173 - - - - 2件: 53, 65 💬
89 Cellule cd34+ autologhe trasdotte con idua lv codificante per il cdna dell'alfa-l-iduronidasi - - - - 1件: 19 💬
90 Certolizumab pegol (cdp870) Certolizumab pegol 1件: D03441 💬 1件: TNF 💬 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 2件: 46, 96 💬
91 Certolizumab pegol (cdp870, czp) Certolizumab pegol 1件: D03441 💬 1件: TNF 💬 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 1件: 96 💬
92 Certolizumab pegol (cdp870, tradename cimzia) Certolizumab pegol 1件: D03441 💬 1件: TNF 💬 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 1件: 46 💬
93 Certolizumab pegol (cdp870, tradename cimzia)(prefilled syringes at the dose of 200mg) Certolizumab pegol 1件: D03441 💬 1件: TNF 💬 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 1件: 46 💬
94 Chimeric human/mouse anti-cd-20 monoclonal antibody - - - - 1件: 46 💬
95 Chx a-dtpa anti-cd66 antibody Pentetic acid 1件: D05422 💬 - - 1件: 28 💬
96 Chx-a-dtpa-anti-cd66 Pentetic acid 1件: D05422 💬 - - 1件: 28 💬
97 Combination of a single dose anti-cd20 antibody and bortezomib Bortezomib 1件: D03150 💬 1件: PSMB5 💬 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 1件: 61 💬
98 Cryopreserved autologous cd34+ cells transduced with a lentiviral vector containing human sgsh gene - - - - 1件: 19 💬
99 Cryopreserved efs-ada lv transduced patient cd34+ cells - - - - 1件: 65 💬
100 Cryopreserved g2scid lentiviral vector transduced patient cd34+ cells - - - - 1件: 65 💬
101 Cytolytic cd4+ t cells - - - - 1件: 13 💬
102 Cytoreductive regimen followed by a cd34+e- selected allogeneic stem cell transplant - - - - 1件: 62 💬
103 D-methylphenidate Methylphenidate 2件: D01296, D04999 💬 2件: SLC6A2, SLC6A3 💬 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 1件: 84 💬
104 Daclizumab (anti-cd25 humanized monoclonal antibody) Daclizumab 1件: D03639 💬 1件: IL2RA 💬 11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 1件: 13 💬
105 Depletion in cd45ra graft donor - - - - 1件: 65 💬
106 Device: cell processing for tcrabeta+/cd19+ depletion - - - - 1件: 65 💬
107 Device: cell processing for tcraß+/cd19+ depletion - - - - 1件: 65 💬
108 Device: clinimacs® cd34 reagent system cell sorter device - - - - 1件: 65 💬
109 Device: miltenyi cd34 reagent system - - - - 1件: 60 💬
110 Diltiazem Diltiazem 3件: D00616, D03830, D07845 💬 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 36件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 3件: 51, 58, 86 💬
111 Diltiazem gel 2% Diltiazem 3件: D00616, D03830, D07845 💬 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 36件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 51 💬
112 Diltiazem hydrochloride Diltiazem 3件: D00616, D03830, D07845 💬 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 36件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 86 💬
113 Duodopa ld/cd 20/5 mg/ml - - - - 1件:  6  💬
114 Ef1as-ada lentiviral vector gene modified autologous cd34+ cells - - - - 1件: 65 💬
115 Ef1as-ada lentiviral vector transduced patient cd34+ cells - - - - 1件: 65 💬
116 Engineered humanized monoclonal anti-human cd19 antibody. - - - - 1件: 46 💬
117 Engineered humanized monoclonal anti-human cd19 antibody. lot numbers: 1-fin-1588 (9.6mg/ml) - - - - 1件: 46 💬
118 Er cd-ld - - - - 1件:  6  💬
119 Ex vivo culture and transduction of the patient's autologous cd34+ hsc with lentivirus vector vsv-g pseudotyped cl20- 4i-ef1a-hyc-opt vector - - - - 1件: 65 💬
120 Ex-vivo expanded autologous human keratinocytes suspension containing epidermal stem cells genetically modified with a gamma-retroviral (rv) vector expressing the full-length lamb3 cdna. - - - - 1件: 36 💬
121 Fc- and cdr-modified humanised monoclonal antibody against c5 - - - - 3件: 11, 62, 109 💬
122 G1xcgd transduced cd34+ cells - - - - 1件: 65 💬
123 Gene-transduced autologous cd34+ stem cells - - - - 1件: 65 💬
124 Genetic: infusion of autologous cryopreserved efs-ada lv cd34+ cells (otl-101) - - - - 1件: 65 💬
125 Genetic: infusion of autologous efs-ada lv cd34+ (otl-101) - - - - 1件: 65 💬
126 Genetic: infusion of autologous efs-ada lv cd34+ cells - - - - 1件: 65 💬
127 Gsk2018682 cd2 capsule - - - - 1件: 13 💬
128 Gsk2018682 cd3 micronised tablet - - - - 1件: 13 💬
129 Gsk2018682 cd3 non-micronised tablet - - - - 1件: 13 💬
130 Gsk2018682 cd3 non-micronised tablet in fed state - - - - 1件: 13 💬
131 Human monoclonal antibody directed against cd20 on b-cells - - - - 1件: 46 💬
132 Humanised anti-cd 20 antibody - - - - 1件: 46 💬
133 Humanised anti-cd4 igg1 monoclonal - - - - 1件: 46 💬
134 Humanized recombinant igg4 monoclonal antibody against cd-127 - - - - 1件: 97 💬
135 Humax-cd20 Ofatumumab 1件: D09314 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 2件: 13, 46 💬
136 Humax-cd38 - - - - 2件: 28, 63 💬
137 Humax-cd4 - - - - 1件: 46 💬
138 Indium 111-radiolabelled anti-cd66 Indium - - - 1件: 28 💬
139 Indium­ 111 ­labelled anti­-cd66 Indium - - - 1件: 28 💬
140 Inebilizumab Inebilizumab 1件: D11757 💬 1件: CD19 💬 5件: B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 3件: 11, 13, 300 💬
141 Ipx203 er cd-ld - - - - 1件:  6  💬
142 Ir cd-ld - - - - 1件:  6  💬
143 Ir cd-ld (carbidopa-levodopa) tablets Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
144 Ir ld / cd - - - - 1件:  6  💬
145 Ir ld/cd - - - - 1件:  6  💬
146 Ld/cd - - - - 1件:  6  💬
147 Lentiviral vector transduced cd34+ cells - - - - 1件: 65 💬
148 Levodopa/carbidopa (ld/cd) Carbidopa 2件: D00059, D00558 💬 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 1件:  6  💬
149 Methylphenidate Methylphenidate 2件: D01296, D04999 💬 2件: SLC6A2, SLC6A3 💬 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 7件:  6 , 13, 34, 84, 113, 179, 206 💬
150 Methylphenidate (mpd) Methylphenidate 2件: D01296, D04999 💬 2件: SLC6A2, SLC6A3 💬 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 1件:  6  💬
151 Methylphenidate (overencapsulated) Methylphenidate 2件: D01296, D04999 💬 2件: SLC6A2, SLC6A3 💬 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 1件: 84 💬
152 Methylphenidate 10mg tablets Methylphenidate 2件: D01296, D04999 💬 2件: SLC6A2, SLC6A3 💬 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 1件: 84 💬
153 Methylphenidate hydrochloride Methylphenidate 2件: D01296, D04999 💬 2件: SLC6A2, SLC6A3 💬 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 2件:  6 , 13 💬
154 Methylphenidate modified release Methylphenidate 2件: D01296, D04999 💬 2件: SLC6A2, SLC6A3 💬 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 1件: 13 💬
155 Methylphenidate modified release 20 mg Methylphenidate 2件: D01296, D04999 💬 2件: SLC6A2, SLC6A3 💬 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 1件: 13 💬
156 Methylphenidate modified release 30 mg Methylphenidate 2件: D01296, D04999 💬 2件: SLC6A2, SLC6A3 💬 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 1件: 13 💬
157 Methylphenidate modified release 40 mg Methylphenidate 2件: D01296, D04999 💬 2件: SLC6A2, SLC6A3 💬 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 1件: 13 💬
158 Methylphenidate, fluoxetin, risperidone Fluoxetine 5件: D00326, D00426, D00823, D01296, D04999 💬 5件: DRD2, HTR2A, SLC6A2, SLC6A3, SLC6A4 💬 14件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Rap1 signaling pathway, Serotonergic synapse, Synaptic vesicle cycle, cAMP signaling pathway 2件: 179, 206 💬
159 Muromonab Muromonab 1件: D05092 💬 3件: CD3D, CD3E, CD3G 💬 11件: Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 1件: 60 💬
160 Muromonab-cd3 Muromonab 1件: D05092 💬 3件: CD3D, CD3E, CD3G 💬 11件: Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 1件: 60 💬
161 Ni-0401 (anti-cd3 mab) Muromonab 1件: D05092 💬 3件: CD3D, CD3E, CD3G 💬 11件: Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 1件: 96 💬
162 Ono-2160/cd - - - - 1件:  6  💬
163 Open-label cdca 250 mg tid Chenodeoxycholic acid 1件: D00163 💬 1件: NR1H4 💬 1件: Bile secretion 1件: 263 💬
164 Other: cd lfd - - - - 1件: 96 💬
165 Other: cd-treat diet - - - - 1件: 96 💬
166 Other: crohn's disease treatment-with-eating diet (cd-treat diet) - - - - 1件: 96 💬
167 Other: diet-cd - - - - 1件: 96 💬
168 Phagocyte oxidase subunit transduced cd34 hematopoietic stem cells - - - - 1件: 65 💬
169 Plerixafor mobilization of autologous cd117 stem cells Plerixafor 1件: D08971 💬 1件: CXCR4 💬 12件: Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral protein interaction with cytokine and cytokine receptor 1件: 299 💬
170 Procedure: autologous cd34+hpc transplantation (hsct) - - - - 1件: 49 💬
171 Procedure: cd3-depleted hematopoietic cell transplantation - - - - 1件: 60 💬
172 Procedure: cd34 selected haploidentical pbsct - - - - 1件: 285 💬
173 Procedure: cd34+ peripheral blood stem cell reinfusion - - - - 1件: 49 💬
174 Procedure: cd3±cd19 depleted hematopoietic stem cell transplantation - - - - 1件: 60 💬
175 Procedure: repair of cdh w/alloderm - - - - 1件: 294 💬
176 Procedure: repair of cdh w/sis gold Gold - - - 1件: 294 💬
177 Rag1 lv cd34+ cells - - - - 1件: 65 💬
178 Recombinant adeno-associated virus 2/6 vector encoding the cdna for human alpha galactosidase a - - - - 1件: 19 💬
179 Rescue medication cdca 250 mg tid Chenodeoxycholic acid 1件: D00163 💬 1件: NR1H4 💬 1件: Bile secretion 1件: 263 💬
180 Retroviral sf71-gp91phox transduced cd34+ cells - - - - 1件: 65 💬
181 Rituximab (anti-cd20) Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 53 💬
182 Routine treatment of cd - - - - 1件: 96 💬
183 Semi continuous intra-oral administration of ld/cd - - - - 1件:  6  💬
184 Standard ld/cd - - - - 1件:  6  💬
185 Suspension of autologous cd34+cells transduced with the g1xcgd viral vector - - - - 1件: 65 💬
186 T-cell depleted & cd34+select/w/stemcell enriched product - - - - 1件: 65 💬
187 Tl011, anti cd20, for the treatment of rheumatoid arthritis - - - - 1件: 46 💬
188 Transduced cd34+ cells - - - - 1件: 285 💬
189 Transduced patient cd34+ cells - - - - 1件: 65 💬
190 Yttrium-90 radiolabelled anti-cd66 antibody Yttrium Y-90 - - - 1件: 28 💬
191 Yttrium­90 radiolabelled anti­cd66 - - - - 1件: 28 💬

先頭へ